Assessing the Role of Quantitative Systems Pharmacology Modeling in Early Stage Drug Development for Urea Cycle Disorders
Presented by Rosa at the American Conference on Pharmacometrics (ACoP), October 2017
Mathematical Modeling of Patient Response and Nonresponse to Therapy
Presented by Takeda and Rosa at the American Conference on Pharmacometrics (ACoP), October 2017
PhysioPD™ Research Enhances Dermatology Research and Drug Development Using Mechanistic Physiological Modeling
Presented by Rosa at the 8th American Conference on Pharmacometrics, October 2017
Virtual Patient Strategies for Quantitative Systems Pharmacology Research
Presented by Rosa at the 8th American Conference on Pharmacometrics, October 2017
Considerations for Adapting Previously Built Models for New Quantitative Systems Pharmacology Research
Presented by Rosa at the 8th American Conference on Pharmacometrics, October 2017
Using Mechanistic Physiological Models to Investigate Responder/Non-Responder Attributes Retrospectively and Prospectively to De-Risk Drug Development
Presented by Rosa at the 8th American Conference on Pharmacometrics, October 2017
Assessing Sodium-Glucose Co-Transporter Inhibition Using a PhysioPD-Style Model
Presented by Sanofi-Aventis and Rosa at the 8th American Conference on Pharmacometrics, October 2017
Development of a Psoriasis PhysioPD™ Platform to Evaluate a Novel Therapy and Identify Uncertainties Critical to Efficacy and Competitive Differentiation
Presented by Grünenthal GmbH and Rosa at 8th American Conference on Pharmacometrics, October 2017
Mechanistic Modeling Using a PhysioPD™ Research Platform Facilitates Identification of Key Pathways Involved in Skin Aging and Potential New Anti-aging Technologies
Presented by Proctor & Gamble and Rosa at the American Conference on Pharmacometrics (ACoP), October 2017
PhysioPD™ Research Utilizes Mechanistic Physiological Models to Enhance Immunology Research and Drug Development.
Presented by Rosa at the American Conference on Pharmacometrics (ACoP), October 2017
Mathematical modeling and analysis using MATLAB and SimBiology to support drug development
Presented by MathWorks and Rosa at the American Conference on Pharmacometrics (ACoP), October 2017
Mechanistic modeling facilitates identification of key pathways involved in dermal aging and potential new targets for anti-aging intervention
Presented by Proctor & Gamble and Rosa at the Society For Investigative Dermatology (SID) Annual Meeting, March 2017
Application of a Qualitative Model to Elucidate the Role of the Alpha-Synuclein System in Parkinson’s Disease
Presented by Elan and Rosa at the 21st International Congress of Parkinson’s Disease and Movement Disorders meeting, June 2017
Mechanistic physiological modeling as a tool for enhancing dermatology research
Presented by Rosa at the Society For Investigative Dermatology (SID) Annual Meeting, March 2017.
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics
Model Qualification Approaches For Quantitative Systems Pharmacology and Mechanistic Physiological Models
Presented by Rosa at American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, 2017
